Global Information
회사소개 | 문의 | 비교리스트

세계의 비효율적 식도운동 치료 시장 : 위식도 역류질환(GERD)과 비만 유병률 상승

Global Market Study on Ineffective Esophageal Motility Treatment: Increasing Prevalence of GERD and Obesity to Propel Market Growth

리서치사 Persistence Market Research
발행일 2020년 06월 상품 코드 952528
페이지 정보 영문 302 Pages
가격
US $ 4,900 ₩ 5,790,000 Unprintable PDF (Single User License)
US $ 7,600 ₩ 8,981,000 PDF (Multi User License)
US $ 10,600 ₩ 12,527,000 PDF (Corporate User License)


세계의 비효율적 식도운동 치료 시장 : 위식도 역류질환(GERD)과 비만 유병률 상승 Global Market Study on Ineffective Esophageal Motility Treatment: Increasing Prevalence of GERD and Obesity to Propel Market Growth
발행일 : 2020년 06월 페이지 정보 : 영문 302 Pages

시장 성장에 영향을 미치는 역학과 시장의 주요 동향 등에 초점을 맞추어 거시경제와 미시적 경제 요인에도 주목하면서 세계의 비효율적 식도운동(Ineffective Esophageal Motility) 치료 시장을 조사했으며, 시장 동향과 수요, 적응증별·최종사용자별·지역별 분석과 예측, 시장 구조 분석, 경쟁 구도 분석 등의 정보를 전해드립니다.

목차

제1장 개요

제2장 시장 개요

  • 조사 대상/분류
  • 시장의 정의/범위/제한

제3장 시장 주요 동향

  • 시장에 영향을 미치는 주요 동향
  • 제품 개발 동향

제4장 시장 배경

  • 거시경제적 요인
    • 세계의 GDP 성장 전망
    • 세계의 의료 업계 전망
    • 1인당 의료비 지출 전망
  • 예측 요인 : 관련성과 영향
    • 라이프스타일 변화와 비만 증가
    • 의약품 개발 기술의 진보
    • 최근의 제품 발매
    • 비효율적 식도운동 발생률 증가
  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 밸류체인 분석

제5장 시장 상황

  • 제품 채택/이용 분석
  • 질병 역학
  • 규제 시나리오
  • 상환 시나리오
  • 기업별 주요 전략

제6장 세계 시장 가격 분석

  • 지역별 가격 분석
  • 평균 가격 분석 벤치마크

제7장 세계 시장 수요 분석과 예측

  • 과거 시장 분석
  • 현재 및 향후 시장 예측
    • 전년대비 성장 동향 분석

제8장 시장 분석과 예측 : 제품별

  • 서론 /주요 조사결과
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 기기
    • 의약품
  • 시장 매력 분석

제9장 시장 분석과 예측 : 적응증별

  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 연하곤란
    • 역류성 식도염
    • 흉부 통증
    • 식도이완 불능증
  • 시장 매력 분석

제10장 시장 분석과 예측 : 최종사용자별

  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 의료기관
    • 소매
  • 시장 매력 분석

제11장 시장 분석과 예측 : 지역별

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 북미
    • 라틴아메리카
    • 유럽
    • 남아시아
    • 동아시아
    • 오세아니아
    • 중동 및 아프리카
  • 시장 매력 분석

제12장 북미 시장 분석과 예측

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 국가별
    • 제품별
    • 적응증별
    • 최종사용자별
  • 시장의 매력 분석
  • 성장 촉진요인 및 저해요인 - 영향 분석

제13장 라틴아메리카 시장 분석과 예측

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 국가별
    • 제품
    • 적응증별
    • 최종사용자별
  • 시장의 매력 분석
  • 성장 촉진요인 및 저해요인 - 영향 분석

제14장 유럽 시장 분석과 예측

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 국가별
    • 제품
    • 적응증별
    • 최종사용자별
  • 시장의 매력 분석
  • 성장 촉진요인 및 저해요인 - 영향 분석

제15장 남아시아 시장 분석과 예측

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 국가별
    • 제품
    • 적응증별
    • 최종사용자별
  • 시장의 매력 분석
  • 성장 촉진요인 및 저해요인 - 영향 분석

제16장 동아시아 시장 분석과 예측

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 국가별
    • 제품
    • 적응증별
    • 최종사용자별
  • 시장의 매력 분석
  • 성장 촉진요인 및 저해요인 - 영향 분석

제17장 오세아니아 시장 분석과 예측

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 국가별
    • 제품
    • 적응증별
    • 최종사용자별
  • 시장의 매력 분석
  • 성장 촉진요인 및 저해요인 - 영향 분석

제18장 중동 및 아프리카 시장 분석과 예측

  • 서론
  • 과거 실적 분석
  • 현재 및 향후 시장 분석과 예측
    • 국가별
    • 제품
    • 적응증별
    • 최종사용자별
  • 시장의 매력 분석
  • 성장 촉진요인 및 저해요인 - 영향 분석

제19장 주요 국가와 신흥국가 시장 분석과 예측

  • 서론
    • 과거 실적 분석
    • 현재 및 향후 시장 분석과 예측
  • 신흥국가 시장 분석
    • 중국
    • 인도
    • 브라질
  • 미국
  • 캐나다
  • 멕시코
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 베네룩스
  • 러시아
  • 일본
  • 한국
  • 호주
  • GCC 국가
  • 남아프리카공화국

제20장 시장 구조 분석

  • 시장 구조 분석 : 기업 Tier별
  • 주요 기업의 시장 점유율 분석
  • 시장 지위 분석
    • 기업별 지역 실적

제21장 경쟁 분석

  • 경쟁 대시보드
  • 경쟁 벤치마크
  • 경쟁 분석
    • Johnson & Johnson
    • Mylan Pharmaceutical
    • MediGus Ltd.
    • Torax Medical
    • Medtronic plc.
    • AstraZeneca plc.
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • GlaxoSmithKline plc.
    • Bayer AG
    • Pfizer Inc.
    • Bausch Health Companies Inc.
    • LABORIE
    • Mederi Therapeutics, Inc.
    • Becton, Dickinson and Company(C. R. Bard, Inc.)
    • EndoGastric Solutions, Inc
    • Olympus
    • Pentax

제22장 조사의 전제조건와 두자어

제23장 조사 방법

LSH 20.08.25

List of Tables:

  • Table 01: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 02: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 03: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 04: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 05: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
  • Table 06: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 07: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 08: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 09: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 10: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 11: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 12: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 13: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 14: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 15: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 16: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 17: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 18: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 19: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 20: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 21: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 22: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 23: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 24: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 25: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 26: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 27: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 28: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 29: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 30: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 31: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 32: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 33: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 34: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 35: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 36: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 37: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 38: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 39: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 40: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 41: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 42: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 43: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 44: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 45: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 46: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 47: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 48: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 49: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 50: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 51: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 52: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

List of Figures:

  • Figure 01: Global Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2019 (A)
  • Figure 02: Global Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2019 (A)
  • Figure 03: Global Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2019 (A)
  • Figure 04: Global Ineffective Esophageal Motility Treatment Market Value Share, By Region, 2019 (A)
  • Figure 05: Primary expected source of payment for visits at which Ineffective Esophageal Motility Treatment were prescribed, by age: United States, 2014-2016
  • Figure 06: Regional Average Pricing Analysis (US$) of Reflux Management Systems (2019A)
  • Figure 07: Regional Average Pricing Analysis (US$) of Endostapler (2019A)
  • Figure 08: Regional Average Pricing Analysis (US$) of Myotomy Devices (2019A)
  • Figure 09: Regional Average Pricing Analysis (US$) of Stretta System (2019A)
  • Figure 10: Global Ineffective Esophageal Motility Treatment Drugs Market Value Analysis and Forecast, 2020-2030 (US$ Mn)
  • Figure 11: Global Ineffective Esophageal Motility Treatment Drugs Market Absolute $ Opportunity (US$ Mn), 2015-2019
  • Figure 12: Global Ineffective Esophageal Motility Treatment Drugs Market Absolute $ Opportunity (US$ Mn), 2020-2030
  • Figure 13: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By Product, 2020 & 2030
  • Figure 14: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By Product, 2020-2030
  • Figure 15: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By Product
  • Figure 16: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By Indication, 2020 & 2030
  • Figure 17: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By Indication, 2020-2030
  • Figure 18: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By Indication
  • Figure 19: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By End User, 2020 & 2030
  • Figure 20: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By End User, 2020-2030
  • Figure 21: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By End User
  • Figure 22: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By Region, 2020 & 2030
  • Figure 23: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By Region, 2020-2030
  • Figure 24: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By Region
  • Figure 25: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 26: North America Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 27: North America Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 28: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 29: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 30: North America Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 31: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 32: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 33: North America Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 34: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 35: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 36: North America Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 37: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 38: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 39: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 40: Latin America Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 41: Latin America Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 42: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 43: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 44: Latin America Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 45: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 46: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 47: Latin America Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 48: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 49: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 50: Latin America Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 51: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 52: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 53: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 54: Europe Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 55: Europe Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 56: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 57: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 58: Europe Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 59: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 60: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 61: Europe Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 62: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 63: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 64: Europe Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 65: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 66: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 67: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 68: East Asia Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 69: East Asia Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 70: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 71: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 72: East Asia Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 73: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 74: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 75: East Asia Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 76: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 77: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 78: East Asia Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 79: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 80: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 81: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 82: South Asia Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 83: South Asia Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 84: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 85: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 86: South Asia Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 87: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 88: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 89: South Asia Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 90: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 91: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 92: South Asia Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 93: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 94: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 95: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 96: Oceania Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 97: Oceania Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 98: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 99: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 100: Oceania Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 101: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 102: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 103: Oceania Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 104: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 105: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 106: Oceania Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 107: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 108: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 109: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 110: MEA Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 111: MEA Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 112: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 113: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 114: MEA Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 115: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 116: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 117: MEA Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 118: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 119: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 120: MEA Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 121: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 122: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 123: US Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 124: US Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 125: US Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 126: Canada Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 127: Canada Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 128: Canada Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 129: Mexico Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 130: Mexico Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 131: Mexico Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 132: U.K. Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 133: U.K. Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 134: U.K. Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 135: Germany Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 136: Germany Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 137: Germany Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 138: France Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 139: France Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 140: France Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 141: Italy Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 142: Italy Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 143: Italy Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 144: Spain Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 145: Spain Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 146: Spain Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 147: BENELUX Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 148: BENELUX Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 149: BENELUX Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 150: Russia Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 151: Russia Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 152: Russia Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 153: Japan Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 154: Japan Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 155: Japan Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 156: South Korea Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 157: South Korea Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 158: South Korea Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 159: Australia Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 160: Australia Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 161: Australia Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 162: GCC Countries Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 163: GCC Countries Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 164: GCC Countries Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 165: South Africa Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 166: South Africa Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 167: South Africa Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)

Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global ineffective esophageal motility treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global ineffective esophageal motility treatment market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the ineffective esophageal motility treatment market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the ineffective esophageal motility treatment market are presented in this comprehensive report, including year-on-year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR's research. This research study can support readers to know the demand for ineffective esophageal motility treatment and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the ineffective esophageal motility treatment market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the ineffective esophageal motility treatment market. The insights and wisdom presented in PMR's study can be leveraged by shareholders in the ineffective esophageal motility treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to macro- as well as micro-economic variables affecting the business scenario in the Ineffective esophageal motility treatment market are also included in the current study. Depending on potential developments in the ineffective esophageal motility treatment market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this ineffective esophageal motility treatment market report, minor companies and new entrants can make suitable company choices to achieve traction in the ineffective esophageal motility treatment market.

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for ineffective esophageal motility treatment market players?
  • Which factors will induce a change in the demand for ineffective esophageal motility treatment during the assessment period?
  • How will changing trends impact the ineffective esophageal motility treatment market?
  • How can market players capture the low-hanging opportunities in the ineffective esophageal motility treatment in developed regions?
  • What are the winning strategies of stakeholders in the ineffective esophageal motility treatment market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the ineffective esophageal motility treatment market?
  • What are the developmental trends in ineffective esophageal motility treatment sectors that will impact the market?
  • How can businesses in the ineffective esophageal motility treatment market avail the growth opportunities in developed and emerging sectors?

Research Methodology:

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the ineffective esophageal motility treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the ineffective esophageal motility treatment market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the ineffective esophageal motility treatment market, and makes PMR's projections on the growth prospects of the ineffective esophageal motility treatment market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Trends
  • 1.3. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Development Trends

4. Market Background

  • 4.1. Macro-Economic Factors
    • 4.1.1. Global GDP Growth Outlook
    • 4.1.2. Global Healthcare Outlook
    • 4.1.3. Per Capita Healthcare Expenditure Outlook
  • 4.2. Forecast Factors - Relevance & Impact
    • 4.2.1. Change in Lifestyle & Growing Obesity Rate
    • 4.2.2. Technological Advancements in Drug Development
    • 4.2.3. Recent Product Launches
    • 4.2.4. Increasing Incidence of Ineffective Esophageal Motility
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity Analysis
  • 4.4. Value Chain Analysis

5. Market Context

  • 5.1. Product Adoption / Usage Analysis
  • 5.2. Disease Epidemiology
  • 5.3. Regulatory Scenario
  • 5.4. Reimbursement Scenario
  • 5.5. Key Strategies Followed By Manufacturers

6. Global Ineffective Esophageal Motility Treatment Market - Pricing Analysis

  • 6.1. Regional Pricing Analysis Product
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global Ineffective Esophageal Motility Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) & Volume Units Analysis Product, 2015 - 2019
  • 8.3. Current and Future Market Size (US$ Mn) & Volume Units Analysis and Forecast Product, 2020 - 2030
    • 8.3.1. Devices
      • 8.3.1.1. Reflux Management Systems
      • 8.3.1.2. Endoscopic Pain Modulators
      • 8.3.1.3. Endostaplers
      • 8.3.1.4. Radiofrequency (RF) Ablation Devices
      • 8.3.1.5. Myotomy Devices
    • 8.3.2. Drugs
      • 8.3.2.1. H2 Receptor Antagonist
      • 8.3.2.2. Antacids
      • 8.3.2.3. Proton Pump Inhibitors
      • 8.3.2.4. Dopamine Antagonist
      • 8.3.2.5. Prokinetic Agents
      • 8.3.2.6. Calcium Channel Blockers
  • 8.4. Market Attractiveness Analysis Product

9. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 - 2019
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020 - 2030
    • 9.3.1. Dysphagia
    • 9.3.2. GERD
    • 9.3.3. Burning chest pain
    • 9.3.4. Achalasia
  • 9.4. Market Attractiveness Analysis By Indication

10. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015 - 2019
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020 - 2030
    • 10.3.1. Institutional sales
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Ambulatory Surgical Centers
    • 10.3.2. Retail Sales
      • 10.3.2.1. Retail Pharmacies
      • 10.3.2.2. Drug Stores
      • 10.3.2.3. Mail order Pharmacies
  • 10.4. Market Attractiveness Analysis By End User

11. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers and Restraints - Impact Analysis

13. Latin America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Rest of Latin America
    • 13.3.2. Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers and Restraints - Impact Analysis

14. Europe Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. South Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. East Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. Oceania Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Northern Africa
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis
    • 19.2.1. China
    • 19.2.2. India
    • 19.2.3. Brazil
  • 19.3. U.S. Ineffective Esophageal Motility Treatment Market Analysis
    • 19.3.1. By Product
    • 19.3.2. By Indication
    • 19.3.3. By End User
  • 19.4. Canada Ineffective Esophageal Motility Treatment Market Analysis
    • 19.4.1. By Product
    • 19.4.2. By Indication
    • 19.4.3. By End User
  • 19.5. Mexico Ineffective Esophageal Motility Treatment Market Analysis
    • 19.5.1. By Product
    • 19.5.2. By Indication
    • 19.5.3. By End User
  • 19.6. U.K. Ineffective Esophageal Motility Treatment Market Analysis
    • 19.6.1. By Product
    • 19.6.2. By Indication
    • 19.6.3. By End User
  • 19.7. Germany Ineffective Esophageal Motility Treatment Market Analysis
    • 19.7.1. By Product
    • 19.7.2. By Indication
    • 19.7.3. By End User
  • 19.8. France Ineffective Esophageal Motility Treatment Market Analysis
    • 19.8.1. By Product
    • 19.8.2. By Indication
    • 19.8.3. By End User
  • 19.9. Italy Ineffective Esophageal Motility Treatment Market Analysis
    • 19.9.1. By Product
    • 19.9.2. By Indication
    • 19.9.3. By End User
  • 19.10. Spain Ineffective Esophageal Motility Treatment Market Analysis
    • 19.10.1. By Product
    • 19.10.2. By Indication
    • 19.10.3. By End User
  • 19.11. BENELUX Ineffective Esophageal Motility Treatment Market Analysis
    • 19.11.1. By Product
    • 19.11.2. By Indication
    • 19.11.3. By End User
  • 19.12. Russia Ineffective Esophageal Motility Treatment Market Analysis
    • 19.12.1. By Product
    • 19.12.2. By Indication
    • 19.12.3. By End User
  • 19.13. Japan Ineffective Esophageal Motility Treatment Market Analysis
    • 19.13.1. By Product
    • 19.13.2. By Indication
    • 19.13.3. By End User
  • 19.14. South Korea Ineffective Esophageal Motility Treatment Market Analysis
    • 19.14.1. By Product
    • 19.14.2. By Indication
    • 19.14.3. By End User
  • 19.15. Australia Ineffective Esophageal Motility Treatment Market Analysis
    • 19.15.1. By Product
    • 19.15.2. By Indication
    • 19.15.3. By End User
  • 19.16. GCC Countries Ineffective Esophageal Motility Treatment Market Analysis
    • 19.16.1. By Product
    • 19.16.2. By Indication
    • 19.16.3. By End User
  • 19.17. South Africa Ineffective Esophageal Motility Treatment Market Analysis
    • 19.17.1. By Product
    • 19.17.2. By Indication
    • 19.17.3. By End User

20. Market Structure Analysis

  • 20.1. Market Structure Analysis by Tier of Companies
  • 20.2. Market Share Analysis for Top Players
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Johnson & Johnson
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
    • 21.3.2. Mylan Pharmaceutical
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
    • 21.3.3. MediGus Ltd.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
    • 21.3.4. Torax Medical
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
    • 21.3.5. Medtronic plc.
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
    • 21.3.6. AstraZeneca plc.
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
    • 21.3.7. Teva Pharmaceutical Industries Ltd.
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
    • 21.3.8. Takeda Pharmaceutical Company Limited
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
    • 21.3.9. GlaxoSmithKline plc.
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
    • 21.3.10. Bayer AG
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
    • 21.3.11. Pfizer Inc.
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.11.4. Sales Footprint
      • 21.3.11.5. Strategy Overview
    • 21.3.12. Bausch Health Companies Inc.
      • 21.3.12.1. Overview
      • 21.3.12.2. Product Portfolio
      • 21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.12.4. Sales Footprint
      • 21.3.12.5. Strategy Overview
    • 21.3.13. LABORIE
      • 21.3.13.1. Overview
      • 21.3.13.2. Product Portfolio
      • 21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.13.4. Sales Footprint
      • 21.3.13.5. Strategy Overview
    • 21.3.14. Mederi Therapeutics, Inc.
      • 21.3.14.1. Overview
      • 21.3.14.2. Product Portfolio
      • 21.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.14.4. Sales Footprint
      • 21.3.14.5. Strategy Overview
    • 21.3.15. Becton, Dickinson and Company (C. R. Bard, Inc.)
      • 21.3.15.1. Overview
      • 21.3.15.2. Product Portfolio
      • 21.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.15.4. Sales Footprint
      • 21.3.15.5. Strategy Overview
    • 21.3.16. EndoGastric Solutions, Inc
      • 21.3.16.1. Overview
      • 21.3.16.2. Product Portfolio
      • 21.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.16.4. Sales Footprint
      • 21.3.16.5. Strategy Overview
    • 21.3.17. Olympus
      • 21.3.17.1. Overview
      • 21.3.17.2. Product Portfolio
      • 21.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.17.4. Sales Footprint
      • 21.3.17.5. Strategy Overview
    • 21.3.18. Pentax
      • 21.3.18.1. Overview
      • 21.3.18.2. Product Portfolio
      • 21.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.18.4. Sales Footprint
      • 21.3.18.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Back to Top
전화 문의
F A Q